Possible Pharmacotherapy of the Opioid κ Receptor Agonist for Drug Dependence

@article{Hasebe2004PossiblePO,
  title={Possible Pharmacotherapy of the Opioid $\kappa$ Receptor Agonist for Drug Dependence},
  author={Ko Hasebe and Koji. Kawai and Tomohiko Suzuki and Kuniaki Kawamura and Toshiaki Tanaka and Minoru Narita and Hiroshi Nagase and Tsutomu Suzuki},
  journal={Annals of the New York Academy of Sciences},
  year={2004},
  volume={1025}
}
Abstract: Because there are few efficacious medications for drug dependence, many clinical trials are being conducted in earnest to find such medications. Considerable evidence has shown that opioid κ receptor agonists attenuate several behavioral responses induced by drugs of abuse. Although this raises the possibility that opioid κ receptor agonists may be useful for the treatment of drug dependence on drugs of abuse, it has been previously reported that treatment with selective opioid… Expand
Behavioural Pharmacology of Novel Kappa Opioid Compounds
Rationale: Kappa opioid receptor (KOPr) activation by traditional agonists has been shown to produce anti-addiction behaviours. However, adverse effects such as sedation, aversion and depression haveExpand
Selective kappa opioid antagonists for treatment of addiction, are we there yet?
TLDR
A comprehensive survey of the KOP antagonists developed for this purpose together with their in vivo studies and clinical trials is presented and a future perspective and recommendations for the work needed to develop clinically relevant KOP antagonist are presented. Expand
Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice
TLDR
Both nalfurafine and U50,488 showed a separation of negative side effects and the modulation of cocaine reward, suggesting this effect of KOR agonists at low doses may be characteristic of the KOR system in general. Expand
Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration
TLDR
Results indicate that activation of the opioid μ1, but not the δ or the κ, receptors is required for the reinforcement of nicotine and suggest that opioid neurotransmission via the μ1 receptors would be a promising target for the development of opioid ligands for smoking cessation. Expand
Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys
Rationale Kappa-opioid receptor (KOR) agonists are antinociceptive but have side effects that limit their therapeutic utility. New KOR agonists have been developed that are fully efficacious at theExpand
Search for the “ideal analgesic” in pain treatment by engineering the mu‐opioid receptor
TLDR
This article decides to explore the possibility of using virus to deliver the mutant mu‐opioid receptor at the various sites of the nociceptive pathway and induce the antinocICEptive responses with the systemic administration of opioid antagonists. Expand
Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats
TLDR
Results suggest that nalfurafine-induced decreases in pain/itch-stimulated behaviors may reflect nonselective decreases in motivated behavior rather than analgesia or antipruritus against the noxious and pruritic stimuli used here. Expand
k Opioids as potential treatments for stimulant dependence
TLDR
A review covers several classes of κ opioid ligands that have been explored for potential treatments of stimulant abuse and includes κ receptor agonists, known to be involved, via indirect effects, in synaptic dopamine levels. Expand
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
TLDR
The findings suggest that nalfurafine is a functionally selective KOR agonists able to selectively activate G protein signaling without activating p38α MAPK may have therapeutic potential as non-dysphoric antipruritic analgesics. Expand
Comparison of the Antinociceptive and Antirewarding Profiles of Novel Bifunctional Nociceptin Receptor/μ-Opioid Receptor Ligands: Implications for Therapeutic Applications
TLDR
It is suggested that NOPr full-agonist activity is required to modulate opioid-induced reward, whereas a bifunctional Nopr/MOPr partial agonist profile may be suitable as a nonaddicting analgesic. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 44 REFERENCES
A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist.
TLDR
Although Spiradoline had promising effects in animal tests of analgesia, and a reasonably good safety profile in preliminary studies, it did not replace morphine as an analgesic and future development of spiradoline-like analgesic compounds should preferably focus on reduction of unwanted effects on the central nervous system. Expand
A novel kappa-opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice.
TLDR
The results suggest that TRK-820-sensitive kappa-opioid receptor subtypes may play a significant role in modulating the development of physical dependence on morphine. Expand
Effects of a newly synthesized κ-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats
TLDR
TRK-820 did not engender cocaine-like responding in rats trained to discriminate between 10 mg/kg cocaine and saline and this results may prompt further investigation of the effectiveness of the new κ-opioid receptor agonist TRk-820 as a novel pharmacotherapeutic compound for the treatment of cocaine addiction. Expand
Involvement of mesolimbic κ-opioid systems in the discriminative stimulus effects of morphine
Abstract The neuroanatomical basis of opiate addiction has been studied using a variety of behavioural techniques. The aim of the present study was to investigate the role of mesolimbic opioidExpand
Differential effects of μ-, δ- and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats
Abstract The effects of selective μ-, δ- and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine were examined in rats trained to discriminate between cocaine (10 mg/kg)Expand
Modulation of the Behavioral and Neurochemical Effects of Psychostimulants by κ‐Opioid Receptor Systems
TLDR
Reviewing the effects of psychostimulant administration on dopaminergic and excitatory amino acid neurotransmission in brain regions comprising the brain's motive circuit provides evidence that the activation of endogenous κ‐opioid receptor systems in these regions opposes the behavioral and neurochemical consequences of repeated drug use. Expand
The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice.
TLDR
It is proposed that TRK-820 may be useful for controlling pain while reducing undesirable side-effects because it suppresses the rewarding and locomotor-enhancing effects of morphine through the activation of kappa-opioid receptors. Expand
Effects of kappa opioids on cocaine self-administration by rhesus monkeys.
TLDR
It is shown that chronic administration of EKC and U50,588 produce a dose-dependent, kappa receptor-mediated and often sustained decrease in cocaine self-administration, which may complicate their use as treatments for cocaine dependence. Expand
Neuropharmacology of cocaine and ethanol dependence.
  • G. Koob, F. Weiss
  • Medicine
  • Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism
  • 1992
TLDR
The results suggest that the neurobiology of drug dependence involves not only neurotransmitters that mediate the acute reinforcing properties of drugs, but also the aversive motivational and emotional aspects of drug withdrawal. Expand
Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist
Abstract TRK-820, a new type of 4,5-epoxymorphinan derivative, was investigated in vivo for antinociceptive activities and its selectivity on various opioid receptors in mice. Trk-820 given s.c. orExpand
...
1
2
3
4
5
...